dc.contributor.author |
Kalkan, Ferhat |
|
dc.contributor.author |
Parlakpinar, Hakan |
|
dc.contributor.author |
Disli, Olcay M. |
|
dc.contributor.author |
Tanriverdi, Lokman H. |
|
dc.contributor.author |
Ozhan, Onural |
|
dc.contributor.author |
Polat, Alaaddin |
|
dc.contributor.author |
Cetin, Asli |
|
dc.contributor.author |
Vardi, Nigar |
|
dc.contributor.author |
Otlu, Yilmaz O. |
|
dc.contributor.author |
Acet, Ahmet |
|
dc.date.accessioned |
2019-07-24T12:55:53Z |
|
dc.date.available |
2019-07-24T12:55:53Z |
|
dc.date.issued |
2018 |
|
dc.identifier.citation |
Kalkan, F. Parlakpinar, H. Disli, OM. Tanriverdi, LH. Ozhan, O. Polat, A. Cetin, A. Vardi, N. Otlu, YO. Acet, A. (2018). Protective and therapeutic effects of dexpanthenol on isoproterenol-induced cardiac damage in rats. Cilt:119 Sayı:9, 7479-7489 ss. |
tr_TR |
dc.identifier.uri |
http://hdl.handle.net/11616/12912 |
|
dc.description.abstract |
The purpose of the study was to explore the protective and therapeutic effects of dexpanthenol (DEX) on isoproterenol (ISO)-induced cardiac damage. Forty rats were distributed into four groups: group I (Control); group II (ISO); ISO (150mg/kg/day) was given to rats once a day for 2 consecutive days with an interval of 24h; group III (DEX+ISO): DEX (250mg/kg) was applied 30min before the first ISO administration and continued in the next two days after second ISO administration; group IV (ISO+DEX): After the ISO treatment at 1st and 2nd days, DEX was given at 3rd and 4th days. Rats were monitored for mean arterial blood pressure (BP), heart rate, oxygen saturation (%SO2), and electrocardiography (ECG). Heart tissue levels of malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), reduced glutathione (GSH), total oxidant status (TOS); total antioxidant capacity (TAC), oxidative stress index (OSI), and caspase-3 were determined. BP and SO2 values indicated a significant decrease in the ISO group. Also, T wave negativity was observed in 6 of 10 rats, SOD, CAT, and GPX levels were significantly lower in ISO group than control group. ISO administration increased TOS and OSI levels, whereas DEX treatment significantly reduced these parameters. Also, ISO-induced morphological alterations such as disorganization of cardiomyocytes, loss of myofibrils and cytoplasmic vacuolization whereas these histological damages were significantly decreased in ISO+DEX and DEX+ISO groups when compared to the ISO group. This study implies the cardioprotective effects of DEX on ISO-induced cardiotoxicity. |
tr_TR |
dc.language.iso |
eng |
tr_TR |
dc.publisher |
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA |
tr_TR |
dc.relation.isversionof |
10.1002/jcb.27058 |
tr_TR |
dc.rights |
info:eu-repo/semantics/restrictedAccess |
tr_TR |
dc.subject |
cardiotoxicity |
tr_TR |
dc.subject |
dexpanthenol |
tr_TR |
dc.subject |
heart |
tr_TR |
dc.subject |
isoproterenol |
tr_TR |
dc.subject |
oxidative stress |
tr_TR |
dc.title |
Protective and therapeutic effects of dexpanthenol on isoproterenol-induced cardiac damage in rats |
tr_TR |
dc.type |
article |
tr_TR |
dc.relation.journal |
Journal of cellular bıochemıstry |
tr_TR |
dc.contributor.department |
İnönü Üniversitesi |
tr_TR |
dc.identifier.volume |
119 |
tr_TR |
dc.identifier.issue |
9 |
tr_TR |
dc.identifier.startpage |
7479 |
tr_TR |
dc.identifier.endpage |
7489 |
tr_TR |